New Partnership Formed to Develop Angelman Syndrome Treatment
source: pixabay.com

New Partnership Formed to Develop Angelman Syndrome Treatment

According to a story from Globe Newswire, the biopharmaceutical company Ovid Therapeutics and the University of Connecticut School of Medicine (UConn) have announced a new license agreement and research collaboration…

Continue Reading New Partnership Formed to Develop Angelman Syndrome Treatment

At 49, She Got Her PhD to Help Her Son With Angelman. Now, She Created COMBINEDBrain To Help Many Related Rare Diseases.

As originally reported in Angelman Syndrome News, Terry Jo Bichell is a PhD researcher, former director and scientific officer of the Angelman Biomarkers and Outcomes Measures Alliance and Tennessee's ambassador…

Continue Reading At 49, She Got Her PhD to Help Her Son With Angelman. Now, She Created COMBINEDBrain To Help Many Related Rare Diseases.
These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies
EliasSch / Pixabay

These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies

According to a story from BioSpace, the gene therapy companies Sarepta Therapeutics, Inc. and StrideBio, Inc. have recently announced the completion of a licensing and collaboration agreement that could lead…

Continue Reading These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies

Tickets are on Sale Now for Rare Disease Film Festival in Boston

Are we ready for our close-up? The second annual Selections from DISORDER: The Rare Disease Film Festival at Biotech Week Boston will be held at the Takeda Auditorium in Cambridge,…

Continue Reading Tickets are on Sale Now for Rare Disease Film Festival in Boston

Gene Therapy for 12 Rare Diseases will be Investigated Thanks to this Industry-Academia Partnership

Extended Collaboration  Amicus Therapeutics has just announced that they are expanding their collaboration with the University of Pennsylvania's Perelman School of Medicine for the next five years. This collaboration is…

Continue Reading Gene Therapy for 12 Rare Diseases will be Investigated Thanks to this Industry-Academia Partnership

Epigenetic Test Developed in UK Could Help Diagnose Genetic Disorders

According to the publication from the London Free Press, a new technique in development at Lawson Health Research Institute uses epigenetics to more closely study genetic expression in humans. Epigenetics…

Continue Reading Epigenetic Test Developed in UK Could Help Diagnose Genetic Disorders

New Technology for Diagnosing Rare Conditions by Photograph May Foster Employment Discrimination?

As discussed in a recent article on PatientWorthy the FDNA has recently developed a new kind of algorithm which can diagnose rare genetic conditions such as Angelman syndrome, Williams syndrome, and Fragile X syndrome using…

Continue Reading New Technology for Diagnosing Rare Conditions by Photograph May Foster Employment Discrimination?
First Patient Enrollment Announced for Angelman Syndrome Nutritional Study
JerzyGorecki / Pixabay

First Patient Enrollment Announced for Angelman Syndrome Nutritional Study

According to a story from BioPortfolio, the keto-medical nutrition company Disruptive Nutrition recently announced that the first patient had been enrolled in a research study which will test a unique…

Continue Reading First Patient Enrollment Announced for Angelman Syndrome Nutritional Study
Angelman Syndrome Clinic Network is Now International
https://pixabay.com/en/hands-world-map-global-earth-600497/

Angelman Syndrome Clinic Network is Now International

Angelman Syndrome (AS) is a neurogenetic disorder. It's not fatal, but prevents patients' from living independently. It causes neurological impairment, seizures, and balance issues among other problems. It's caused by a…

Continue Reading Angelman Syndrome Clinic Network is Now International

A Recent Study Has Found That Minocycline Doesn’t Benefit People with Angelman Syndrome

The drug minocycline is a tetracycline antibiotic. Previous research using mouse models has indicated that it may have anti-inflammatory and antiapoptotic (prevents cell death) properties and may benefit some neurological…

Continue Reading A Recent Study Has Found That Minocycline Doesn’t Benefit People with Angelman Syndrome
With Its Own Disease Code, Angelman Syndrome Will be Easier to Research and Monitor
Source: Pixabay

With Its Own Disease Code, Angelman Syndrome Will be Easier to Research and Monitor

According to a story from Angelman Syndrome news, Angelman syndrome was recently given its own disease unique disease code: Q93.51. The new code will help make researching and tracking the…

Continue Reading With Its Own Disease Code, Angelman Syndrome Will be Easier to Research and Monitor
Close Menu